AbbVie is aiming to position Vuity as a first-line option for people newly-diagnosed with mild-to-moderate presbyopia, either as an alternative to reading glasses or as an add-on that can give ...

New Delhi: Days after Mumbai-based Entod Pharmaceuticals' claimed that their new eye drops could reduce the need for reading glasses in people with presbyopia, the DCGI has suspended the company's ...

Understanding vision requirements, selecting the right lens materials and considering protective coatings can make ...

However, Entod Pharmaceuticals has introduced PresVu, India's first eye drop designed specifically to reduce dependence on ...

Allergan sees Vuity as being a first-line treatment for people newly-diagnosed with mild-to-moderate presbyopia, or as an adjunct to reading glasses for people who want more flexibility in their life.

With the new drops, though, the 54-year-old retail consultant is able to put the drops in and then read without wearing any reading glasses. The medicine can be used to treat presbyopia ...

In a phase 3 trial, Tenpoint Therapeutics’ eye drop—a combination of carbachol and brimonidine—improved vision for patients with presbyopia for up to eight hours. The top-line results come f ...